Inhibitor kappaB and nuclear factor kappaB in granulocyte-macrophage colony-stimulating factor antagonism of dexamethasone suppression of the macrophage response to Aspergillus fumigatus conidia

التفاصيل البيبلوغرافية
العنوان: Inhibitor kappaB and nuclear factor kappaB in granulocyte-macrophage colony-stimulating factor antagonism of dexamethasone suppression of the macrophage response to Aspergillus fumigatus conidia
المؤلفون: Elmer Brummer, David A. Stevens, Patricia P. Jones, Young Jun Kang, Jung Hyun Choi
المصدر: The Journal of infectious diseases. 193(7)
سنة النشر: 2005
مصطلحات موضوعية: Male, medicine.medical_treatment, Blotting, Western, Anti-Inflammatory Agents, Dexamethasone, Aspergillus fumigatus, Microbiology, Proinflammatory cytokine, Cell Line, Mice, Western blot, polycyclic compounds, medicine, Immunology and Allergy, Macrophage, Animals, Aspergillosis, Cells, Cultured, medicine.diagnostic_test, biology, Macrophages, Intracellular Signaling Peptides and Proteins, Granulocyte-Macrophage Colony-Stimulating Factor, NF-kappa B p50 Subunit, Proteins, Spores, Fungal, biology.organism_classification, Molecular biology, Blot, Infectious Diseases, Granulocyte macrophage colony-stimulating factor, Cytokine, Cell culture, hormones, hormone substitutes, and hormone antagonists, medicine.drug
الوصف: Background The dexamethasone (DEX) immunosuppressive effect on macrophage killing activity and cytokine production in response to Aspergillus fumigatus conidia is antagonized by granulocyte-macrophage colony-stimulating factor (GM-CSF). The molecular mechanism is unknown. We postulated that this antagonism is mediated by inhibitor kappaB (I kappaB) induction by DEX and is opposed by acceleration of I kappaB degradation by GM-CSF with or without conidia stimulation, with corresponding effects on translocation and activation of nuclear factor kappa B (NF-kappaB). Methods We studied 2 types of cells, resident peritoneal macrophages from CD-1 mice and the murine macrophage RAW264.7 cell line. Cells were unstimulated or stimulated with conidia and simultaneously treated with DEX, GM-CSF, or DEX plus GM-CSF, for 2-4 hours. I kappaB degradation and NF-kappaB activation were assessed by Western blot. Results Macrophages stimulated with conidia alone increased NF-kappaB translocation. DEX increased I kappaB levels in cytoplasm and blocked translocation of NF-kappaB to the nucleus in unstimulated and conidia-stimulated macrophages. Conversely, GM-CSF decreased I kappaB levels. GM-CSF reversed the effect of DEX on I kappaB levels. NF-kappaB levels were minimal in DEX-treated macrophage nuclear extracts, compared with those from GM-CSF-treated and GM-CSF plus DEX-treated macrophages. Conclusion GM-CSF can reverse the DEX immunosuppressive effect by enhancing I kappaB degradation and promoting NF-kappaB translocation. This would allow macrophage production of proinflammatory cytokines, facilitating resistance to aspergillosis.
تدمد: 0022-1899
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19b7f19f4cc34f214288656c8501e1b9
https://pubmed.ncbi.nlm.nih.gov/16518765
Rights: OPEN
رقم الانضمام: edsair.doi.dedup.....19b7f19f4cc34f214288656c8501e1b9
قاعدة البيانات: OpenAIRE